Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-007023
Filing Date
2013-12-26
Accepted
2013-12-26 16:09:08
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm 10-Q 1603541
2 CERTIFICATION cbmg_ex311.htm EX-31.1 18535
3 CERTIFICATION cbmg_ex312.htm EX-31.2 18723
4 CERTIFICATION cbmg_ex321.htm EX-32.1 11098
  Complete submission text file 0001354488-13-007023.txt   6918339

Data Files

Seq Description Document Type Size
5 cmbg-20130930.xml EX-101.INS 988758
6 cmbg-20130930.xsd EX-101.SCH 48351
7 cmbg-20130930_cal.xml EX-101.CAL 58878
8 cmbg-20130930_def.xml EX-101.DEF 105840
9 cmbg-20130930_lab.xml EX-101.LAB 297931
10 cmbg-20130930_pre.xml EX-101.PRE 225903
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52282 | Film No.: 131298807
SIC: 6199 Finance Services